Invest
University of Queensland terminates COVID vaccine trial after ‘unexpected’ results
Invest
University of Queensland terminates COVID vaccine trial after ‘unexpected’ results
Australia has terminated its COVID-19 vaccine trial after several test participants returned false HIV results during Phase 1 of the trial.
University of Queensland terminates COVID vaccine trial after ‘unexpected’ results
Australia has terminated its COVID-19 vaccine trial after several test participants returned false HIV results during Phase 1 of the trial.
While the University of Queensland (UQ) and CSL announced on Friday that the Phase 1 trial of their COVID-19 vaccine has shown that it elicits a “robust response” towards the virus and has a “strong safety profile”, UQ confirmed that the government has pulled the plug on further trials.
Australia has been anticipating an update from the University of Queensland after it commenced a Phase 1 trial of their COVID-19 jab candidate – V451 – in July 2020.
That announcement came on Friday, with UQ revealing that “there were no serious adverse events of safety concerns reported in the 216 trial participants”. However, several trial participants did return false positive HIV test results.
As a result, the government has decided to terminate its $1 billion deal with UQ and global biotech company CSL, after agreeing to buy over 50 million doses.
Defending its position, UQ explained on Friday that the generation of antibodies directed towards fragments of a protein, which is a component used to stabilise the vaccine, may cause a partial immune response, but that it was unexpected that the levels induced would interfere with certain HIV tests.
UQ confirmed, however, that there “is no possibility the vaccine causes infection”, and routine follow-up tests confirmed there is no HIV virus present.
But it did admit that for the vaccine to be rolled out, “significant changes” would need to be made to well-established HIV testing procedures in the healthcare setting.
Professor Paul Young, UQ vaccine co-lead, said that although it was possible to re-engineer the vaccine, the team did not have the luxury of time needed.
“Doing so would set back development by another 12 or so months, and while this is a tough decision to take, the urgent need for a vaccine has to be everyone’s priority.
“I said at the start of vaccine development that there were no guarantees, but what is really encouraging is that the core technology approach we used has passed the major clinical test. It is a safe and well-tolerated vaccine, producing the strong virus-neutralising effect that we were hoping to see,” Mr Young said.
“So, we will continue to push forward, and we are confident that with further work, the Molecular Clamp technology will be a robust platform for future vaccine development here in Australia and to meet future biosecurity needs.”
The UQ V451 vaccine was one of four the Australian government had hoped would be successful in the fight against the coronavirus pandemic.
RELATED ARTICLES
About the author
About the author
Economy
Inflation concerns grow as consumer price index rises, prompting potential interest rate hikes
The latest Consumer Price Index (CPI) data has sparked fresh concerns about inflation in Australia, with experts suggesting that further interest rate hikes may be on the horizon. The CPI, a key ...Read more
Economy
State Street economist comments on latest labour force data amid market anticipation
The latest labour force data, released today, has prompted a measured response from financial experts, with insights provided by Krishna Bhimavarapu, APAC Economist at State Street Investment ...Read more
Economy
RBA's interest rate hike impacts Australian employment landscape
The Reserve Bank of Australia (RBA) has decided to increase interest rates by 25 basis points, raising the cash rate to 3.85%. This move, aimed at controlling inflation, has elicited responses from ...Read more
Economy
RBA’s latest rate hike sparks debate over economic impact
In a surprising move, the Reserve Bank of Australia (RBA) has increased the cash rate, signalling a significant shift in its monetary policy approach. This decision comes amid a backdrop of unexpected ...Read more
Economy
When inflation reopens the rate door: A broker-sector case study in defending margins, clients and share
Australia’s latest trimmed-mean inflation reading at 3.3% has revived the prospect of another Reserve Bank move and put lenders, brokers and borrowers back on a tightening footing. This case study ...Read more
Economy
Inflation rise dampens hopes for interest rate cuts as employment dynamics shift
In a development that has dashed hopes for an interest rate cut, Australia's Consumer Price Index (CPI) has surged back to 3.8%, erasing the progress made since October. This unexpected rise in ...Read more
Economy
Inflation surge poses challenges for small businesses and consumers
The latest inflation figures have sparked concern among Australian businesses and consumers alike, with the rising costs expected to influence the Reserve Bank of Australia's (RBA) upcoming interest ...Read more
Economy
Australia’s spending surprise raises the odds of a February rate move — here’s how to protect margin and momentum
Household outlays are running hotter than economists expected, with the latest ABS readings showing broad-based gains across services and goods. That resilience is exactly the kind of demand impulse ...Read more
Economy
Inflation concerns grow as consumer price index rises, prompting potential interest rate hikes
The latest Consumer Price Index (CPI) data has sparked fresh concerns about inflation in Australia, with experts suggesting that further interest rate hikes may be on the horizon. The CPI, a key ...Read more
Economy
State Street economist comments on latest labour force data amid market anticipation
The latest labour force data, released today, has prompted a measured response from financial experts, with insights provided by Krishna Bhimavarapu, APAC Economist at State Street Investment ...Read more
Economy
RBA's interest rate hike impacts Australian employment landscape
The Reserve Bank of Australia (RBA) has decided to increase interest rates by 25 basis points, raising the cash rate to 3.85%. This move, aimed at controlling inflation, has elicited responses from ...Read more
Economy
RBA’s latest rate hike sparks debate over economic impact
In a surprising move, the Reserve Bank of Australia (RBA) has increased the cash rate, signalling a significant shift in its monetary policy approach. This decision comes amid a backdrop of unexpected ...Read more
Economy
When inflation reopens the rate door: A broker-sector case study in defending margins, clients and share
Australia’s latest trimmed-mean inflation reading at 3.3% has revived the prospect of another Reserve Bank move and put lenders, brokers and borrowers back on a tightening footing. This case study ...Read more
Economy
Inflation rise dampens hopes for interest rate cuts as employment dynamics shift
In a development that has dashed hopes for an interest rate cut, Australia's Consumer Price Index (CPI) has surged back to 3.8%, erasing the progress made since October. This unexpected rise in ...Read more
Economy
Inflation surge poses challenges for small businesses and consumers
The latest inflation figures have sparked concern among Australian businesses and consumers alike, with the rising costs expected to influence the Reserve Bank of Australia's (RBA) upcoming interest ...Read more
Economy
Australia’s spending surprise raises the odds of a February rate move — here’s how to protect margin and momentum
Household outlays are running hotter than economists expected, with the latest ABS readings showing broad-based gains across services and goods. That resilience is exactly the kind of demand impulse ...Read more
